Earnings call transcript: HCI Group Q1 2026 sees record EPS, stock dips slightly

HCI Group reported Q1 2026 diluted EPS of $5.45, ahead of the $5.24 forecast, with revenue up 12.3% YoY and pre-tax income rising 15% to $115 million. Management highlighted a 57% combined ratio, 35% after-tax ROE, a 6% debt-to-capital ratio, and continued buybacks under an $80 million authorization. Shares still slipped 0.56% in after-hours trading, but the earnings and capital-return profile remain strong.

Analysis

HCI is trading like a quality insurer that the market still treats as a weather-sensitive cyclical, when the more important story is capital compounding plus embedded asset value. The cleanest second-order read is that buybacks matter more here than at a typical carrier: with low leverage and excess liquidity, every repurchased share lifts per-share economics while the firm is still growing book value, so the EPS runway can stay intact even if premium growth stays flat. That makes the stock more resilient than headline premium trends imply, especially if investment income remains a meaningful tailwind.

The market is likely underestimating how much the softening reinsurance backdrop helps HCI’s economics over the next 1-2 placement cycles. More internal risk retention via captive/reinsurance structure should improve margin durability and reduce frictional reinsurance spend, but it also raises earnings beta to catastrophe seasons: a benign hurricane window is the key catalyst for the bull case, while an active storm year would expose how much of the current operating leverage is timing-driven. The ideal setup is a few quiet months into June placements, which could re-rate the stock before the market fully absorbs the buyback math.

Contrarian angle: the main debate is not whether HCI is cheap, but whether Exzeo and adjacent initiatives can keep creating incremental equity value without distracting capital from the core underwriting engine. If those ventures continue to scale, the market may be using the wrong multiple by valuing HCI as a pure insurer rather than a capital allocator with operating subsidiaries and a monetizable technology asset. The risk is that investors overpay for optionality today; the opportunity is that the stock still doesn’t seem to fully credit the sum-of-the-parts.

OPY is a beneficiary only indirectly, if at all; the cleaner relative trade is to own HCI versus broader insurance peers that lack a visible buyback + embedded-asset story. The next inflection point is likely the June 1 reinsurance announcement: a favorable placement could drive a fast re-rating over days, while a bad storm season or unexpectedly higher retained risk would be a months-long overhang.

Key Decisions for Investors

• Long HCI vs. a property-casualty peer basket for 1-3 months: thesis is per-share compounding + buybacks + balance-sheet optionality; risk is a noisy hurricane season or a weak June reinsurance outcome.
• Buy HCI on any post-earnings or pre-placement dip, targeting a 10-15% move if the June 1 reinsurance program confirms better retention economics and buybacks continue at the current pace.
• For upside convexity, consider HCI call spreads out 2-4 months to capture a re-rating on capital-return optics and special-value asset recognition; risk/reward is better than straight equity if volatility remains elevated.
• If you want hedged exposure, pair long HCI against a higher-leverage Florida insurer or a name with weaker buyback capacity; the relative multiple gap should widen if the market starts rewarding balance-sheet strength.
• Take profits partially if the stock moves sharply into the June placement announcement without evidence of improved economics; the event can be a sell-the-news catalyst if expectations get ahead of fundamentals.